Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Thomas Sferra, MD

Showing   of 2 results

Getty C.Difficile bacteria illustration

UH Rainbow Gastroenterology Chief Plays Pivotal Role in FDA Approval of C. difficile Drug in Kids

Clinical trial results support extrapolation to the pediatric population of bezlotoxumab efficacy and safety established in adults - Innovations in Pediatrics | Fall 2023

New Trial at UH Rainbow Evaluating Treatment to Prevent Recurrent C difficile Infection in Children

UH Clinical Update - August 2018 The incidence of C. difficile infection is increasing in children.   “We don’t have a good sense of why it’s on the rise in kids,” says Thomas Sferra, MD, Division Chief of Pediatric Gastroenterology at UH...

Results are loading...